Aptose Biosciences: Q3 Earnings Snapshot
Will provide a clinical update on Monday, October 30, 2023, in conjunction with poster presentations ...
Announced that two abstracts on tuspetinib, Aptose’s Phase 1/2 myeloid kinase inhibitor in development ...
Announced that the Aptose management team will participate in the H.C. Wainwright 25th Annual Global ...
Aptose Biosciences: Q2 Earnings Snapshot
Announced today that the company management team will provide a clinical update on Saturday, June 10, ...
Aptose Biosciences: Q1 Earnings Snapshot
Announced it has entered into an equity distribution agreement with JonesTrading Institutional Services ...
Has entered into an equity distribution agreement with JonesTrading Institutional Services LLC, as agent. ...
Aptose Biosciences: Q3 Earnings Snapshot